instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'AZACITIDINE'? | Anti-CD19 CAR T-cell therapy remission despite prior anti-CD19 antibody Tafasitamab in relapsed/refractory DLBCL.
Tafasitamab (MOR208) is an Fc-enhanced, humanized, monoclonal antibody that targets CD19. The L-MIND (NCT02399085) trial, an open-label, single-arm, phase II study of Tafasitamab (TAFA) plus lenalidomide (L... | 2 CYCLES | DrugDosageText | CC BY-NC-ND | 34354920 | 19,843,222 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | Anti-CD19 CAR T-cell therapy remission despite prior anti-CD19 antibody Tafasitamab in relapsed/refractory DLBCL.
Tafasitamab (MOR208) is an Fc-enhanced, humanized, monoclonal antibody that targets CD19. The L-MIND (NCT02399085) trial, an open-label, single-arm, phase II study of Tafasitamab (TAFA) plus lenalidomide (L... | UNK, 6 CYCLES (DA-R-EPOCH) | DrugDosageText | CC BY-NC-ND | 34354920 | 20,181,118 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | CILASTATIN SODIUM\IMIPENEM, CLARITHROMYCIN, LINEZOLID, TIGECYCLINE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 34355067 | 19,698,843 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Incorrect product administration duration'. | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | CLARITHROMYCIN, TEDIZOLID PHOSPHATE, TIGECYCLINE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 34355067 | 19,668,790 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral motor neuropathy'. | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | CILASTATIN SODIUM\IMIPENEM, CLARITHROMYCIN, LINEZOLID, TIGECYCLINE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 34355067 | 19,698,843 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin bacterial infection'. | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | AZITHROMYCIN ANHYDROUS, CILASTATIN SODIUM\IMIPENEM, CLARITHROMYCIN, LINEZOLID, MYCOPHENOLATE MOFETIL, PREDNISOLONE, TEDIZOLID, TIGECYCLINE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 34355067 | 19,701,084 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | CILASTATIN SODIUM\IMIPENEM, CLARITHROMYCIN, LINEZOLID, TIGECYCLINE, TOBRAMYCIN | DrugsGivenReaction | CC BY | 34355067 | 19,698,843 | 2021-08 |
What was the administration route of drug 'CILASTATIN SODIUM\IMIPENEM'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34355067 | 19,701,084 | 2021-08 |
What was the administration route of drug 'CLARITHROMYCIN'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Oral | DrugAdministrationRoute | CC BY | 34355067 | 19,701,084 | 2021-08 |
What was the administration route of drug 'LINEZOLID'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34355067 | 19,701,084 | 2021-08 |
What was the administration route of drug 'TEDIZOLID PHOSPHATE'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34355067 | 19,668,790 | 2021-08 |
What was the administration route of drug 'TEDIZOLID'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34355067 | 19,701,084 | 2021-08 |
What was the administration route of drug 'TIGECYCLINE'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34355067 | 19,701,084 | 2021-08 |
What was the administration route of drug 'TOBRAMYCIN'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34355067 | 19,701,084 | 2021-08 |
What was the dosage of drug 'TEDIZOLID PHOSPHATE'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | 200 MG, OD (ALSO REPORTED AS BD) | DrugDosageText | CC BY | 34355067 | 19,668,790 | 2021-08 |
What was the outcome of reaction 'Axonal neuropathy'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Not recovered | ReactionOutcome | CC BY | 34355067 | 19,698,843 | 2021-08 |
What was the outcome of reaction 'Deafness neurosensory'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Not recovered | ReactionOutcome | CC BY | 34355067 | 19,701,084 | 2021-08 |
What was the outcome of reaction 'Drug intolerance'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Recovered | ReactionOutcome | CC BY | 34355067 | 19,698,843 | 2021-08 |
What was the outcome of reaction 'Mycobacterium chelonae infection'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Recovered | ReactionOutcome | CC BY | 34355067 | 19,701,084 | 2021-08 |
What was the outcome of reaction 'Neuropathy peripheral'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Not recovered | ReactionOutcome | CC BY | 34355067 | 19,668,790 | 2021-08 |
What was the outcome of reaction 'Off label use'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Recovered | ReactionOutcome | CC BY | 34355067 | 19,724,827 | 2021-08 |
What was the outcome of reaction 'Peripheral motor neuropathy'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Not recovered | ReactionOutcome | CC BY | 34355067 | 19,698,843 | 2021-08 |
What was the outcome of reaction 'Peroneal nerve palsy'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Not recovered | ReactionOutcome | CC BY | 34355067 | 19,698,843 | 2021-08 |
What was the outcome of reaction 'Platelet count decreased'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Recovered | ReactionOutcome | CC BY | 34355067 | 19,701,084 | 2021-08 |
What was the outcome of reaction 'Skin bacterial infection'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Recovered | ReactionOutcome | CC BY | 34355067 | 19,701,084 | 2021-08 |
What was the outcome of reaction 'Thrombocytopenia'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Recovered | ReactionOutcome | CC BY | 34355067 | 19,701,084 | 2021-08 |
What was the outcome of reaction 'Toxicity to various agents'? | Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection.
Cutaneous non-tuberculous mycobacterial (NTM) infections are an emerging infectious disease and require a protracted course of combination antibiotics. Antimicrobial choice is limited by resistance and toxicity. Tedizolid is a new oxazolidino... | Recovered | ReactionOutcome | CC BY | 34355067 | 19,698,843 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Derealisation'. | Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Carbamazepine and oxcarbazepine are used for behavioral disorders following organic diseases. After severe acquired brain injury, patients may develop frontal symptoms. In our neurological rehabilitation routine, oxcarbazepine is u... | OXCARBAZEPINE | DrugsGivenReaction | CC BY | 34356183 | 20,482,281 | 2021-07-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Carbamazepine and oxcarbazepine are used for behavioral disorders following organic diseases. After severe acquired brain injury, patients may develop frontal symptoms. In our neurological rehabilitation routine, oxcarbazepine is u... | OXCARBAZEPINE | DrugsGivenReaction | CC BY | 34356183 | 20,439,722 | 2021-07-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mutism'. | Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Carbamazepine and oxcarbazepine are used for behavioral disorders following organic diseases. After severe acquired brain injury, patients may develop frontal symptoms. In our neurological rehabilitation routine, oxcarbazepine is u... | OXCARBAZEPINE | DrugsGivenReaction | CC BY | 34356183 | 20,482,281 | 2021-07-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Carbamazepine and oxcarbazepine are used for behavioral disorders following organic diseases. After severe acquired brain injury, patients may develop frontal symptoms. In our neurological rehabilitation routine, oxcarbazepine is u... | OXCARBAZEPINE | DrugsGivenReaction | CC BY | 34356183 | 20,439,722 | 2021-07-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psychotic behaviour'. | Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Carbamazepine and oxcarbazepine are used for behavioral disorders following organic diseases. After severe acquired brain injury, patients may develop frontal symptoms. In our neurological rehabilitation routine, oxcarbazepine is u... | OXCARBAZEPINE | DrugsGivenReaction | CC BY | 34356183 | 20,482,281 | 2021-07-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Carbamazepine and oxcarbazepine are used for behavioral disorders following organic diseases. After severe acquired brain injury, patients may develop frontal symptoms. In our neurological rehabilitation routine, oxcarbazepine is u... | OXCARBAZEPINE | DrugsGivenReaction | CC BY | 34356183 | 20,439,722 | 2021-07-19 |
What was the outcome of reaction 'Derealisation'? | Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Carbamazepine and oxcarbazepine are used for behavioral disorders following organic diseases. After severe acquired brain injury, patients may develop frontal symptoms. In our neurological rehabilitation routine, oxcarbazepine is u... | Recovering | ReactionOutcome | CC BY | 34356183 | 20,482,281 | 2021-07-19 |
What was the outcome of reaction 'Hyponatraemia'? | Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Carbamazepine and oxcarbazepine are used for behavioral disorders following organic diseases. After severe acquired brain injury, patients may develop frontal symptoms. In our neurological rehabilitation routine, oxcarbazepine is u... | Recovered | ReactionOutcome | CC BY | 34356183 | 20,439,722 | 2021-07-19 |
What was the outcome of reaction 'Mutism'? | Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Carbamazepine and oxcarbazepine are used for behavioral disorders following organic diseases. After severe acquired brain injury, patients may develop frontal symptoms. In our neurological rehabilitation routine, oxcarbazepine is u... | Recovering | ReactionOutcome | CC BY | 34356183 | 20,482,281 | 2021-07-19 |
What was the outcome of reaction 'Psychotic behaviour'? | Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Carbamazepine and oxcarbazepine are used for behavioral disorders following organic diseases. After severe acquired brain injury, patients may develop frontal symptoms. In our neurological rehabilitation routine, oxcarbazepine is u... | Recovering | ReactionOutcome | CC BY | 34356183 | 20,482,281 | 2021-07-19 |
What was the outcome of reaction 'Seizure'? | Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Carbamazepine and oxcarbazepine are used for behavioral disorders following organic diseases. After severe acquired brain injury, patients may develop frontal symptoms. In our neurological rehabilitation routine, oxcarbazepine is u... | Recovered | ReactionOutcome | CC BY | 34356183 | 20,439,722 | 2021-07-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse drug reaction'. | Somatic Tumor Profile Analysis in a Patient with Germline PMS2 Mutation and Synchronous Ovarian and Uterine Carcinomas.
Lynch syndrome patients with synchronous endometrial and ovarian cancer (SEOC) are rare. When these cases occur, they are most often endometrioid histology and early grade. Early-grade tumors are not ... | CARBOPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY | 34357101 | 20,196,946 | 2021-07-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Somatic Tumor Profile Analysis in a Patient with Germline PMS2 Mutation and Synchronous Ovarian and Uterine Carcinomas.
Lynch syndrome patients with synchronous endometrial and ovarian cancer (SEOC) are rare. When these cases occur, they are most often endometrioid histology and early grade. Early-grade tumors are not ... | CARBOPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY | 34357101 | 20,217,154 | 2021-07-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delirium'. | Transient glyphosate encephalopathy due to a suicide attempt.
Glyphosate-containing herbicides are less toxic than paraquat and are one of the most widely used herbicides today.
We report a case of ingestion of a pesticide containing glyphosate in a suicide attempt. The patient was admitted to the psychiatric depart... | LEVETIRACETAM, MIRTAZAPINE, RISPERIDONE | DrugsGivenReaction | CC BY | 34357684 | 20,084,823 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalopathy'. | Transient glyphosate encephalopathy due to a suicide attempt.
Glyphosate-containing herbicides are less toxic than paraquat and are one of the most widely used herbicides today.
We report a case of ingestion of a pesticide containing glyphosate in a suicide attempt. The patient was admitted to the psychiatric depart... | LEVETIRACETAM | DrugsGivenReaction | CC BY | 34357684 | 19,993,839 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Transient glyphosate encephalopathy due to a suicide attempt.
Glyphosate-containing herbicides are less toxic than paraquat and are one of the most widely used herbicides today.
We report a case of ingestion of a pesticide containing glyphosate in a suicide attempt. The patient was admitted to the psychiatric depart... | LEVETIRACETAM, MIRTAZAPINE, RISPERIDONE | DrugsGivenReaction | CC BY | 34357684 | 20,084,823 | 2021-09 |
What was the outcome of reaction 'Delirium'? | Transient glyphosate encephalopathy due to a suicide attempt.
Glyphosate-containing herbicides are less toxic than paraquat and are one of the most widely used herbicides today.
We report a case of ingestion of a pesticide containing glyphosate in a suicide attempt. The patient was admitted to the psychiatric depart... | Recovering | ReactionOutcome | CC BY | 34357684 | 20,084,823 | 2021-09 |
What was the outcome of reaction 'Encephalopathy'? | Transient glyphosate encephalopathy due to a suicide attempt.
Glyphosate-containing herbicides are less toxic than paraquat and are one of the most widely used herbicides today.
We report a case of ingestion of a pesticide containing glyphosate in a suicide attempt. The patient was admitted to the psychiatric depart... | Recovering | ReactionOutcome | CC BY | 34357684 | 19,993,839 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis.
Candida parapsilosis infections are increasingly reported in preterm neonates, but the optimal treatment remains uncertain. We report the clinical history of an extremely pre... | DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IMIPENEM, NOREPINEPHRINE, VANCOMYCIN, VASOPRESSIN | DrugsGivenReaction | CC BY | 34358040 | 19,974,257 | 2021-07-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Systemic candida'. | Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis.
Candida parapsilosis infections are increasingly reported in preterm neonates, but the optimal treatment remains uncertain. We report the clinical history of an extremely pre... | DOPAMINE HYDROCHLORIDE, EPINEPHRINE, IMIPENEM, NOREPINEPHRINE, VANCOMYCIN, VASOPRESSIN | DrugsGivenReaction | CC BY | 34358040 | 19,974,257 | 2021-07-13 |
What is the weight of the patient? | Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis.
Candida parapsilosis infections are increasingly reported in preterm neonates, but the optimal treatment remains uncertain. We report the clinical history of an extremely pre... | 1.6 kg. | Weight | CC BY | 34358040 | 19,943,485 | 2021-07-13 |
What was the dosage of drug 'LEVOTHYROXINE'? | Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis.
Candida parapsilosis infections are increasingly reported in preterm neonates, but the optimal treatment remains uncertain. We report the clinical history of an extremely pre... | 2 MICROGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 34358040 | 19,943,485 | 2021-07-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to adrenals'. | Re-Challenging with Nivolumab in Metastatic Renal Cell Carcinoma After Immune-Related Interstitial Pneumonia: A Case Report.
BACKGROUND The efficacy and safety of re-challenge with immune checkpoint inhibitors after immune-related adverse events have not been established. We report a case of successful re-administratio... | AXITINIB, EVEROLIMUS, PAZOPANIB, SORAFENIB, SUNITINIB | DrugsGivenReaction | CC BY-NC-ND | 34358221 | 19,773,432 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to lung'. | Re-Challenging with Nivolumab in Metastatic Renal Cell Carcinoma After Immune-Related Interstitial Pneumonia: A Case Report.
BACKGROUND The efficacy and safety of re-challenge with immune checkpoint inhibitors after immune-related adverse events have not been established. We report a case of successful re-administratio... | AXITINIB, EVEROLIMUS, PAZOPANIB, SORAFENIB, SUNITINIB | DrugsGivenReaction | CC BY-NC-ND | 34358221 | 19,773,432 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetes mellitus'. | Efficacy and Tolerability of Methotrexate and Methylprednisolone in a Comparative Assessment of the Primary and Long-Term Outcomes in Patients with Pulmonary Sarcoidosis.
BACKGROUND
There is insufficient information in the literature on the comparative efficacy and tolerability of methotrexate (MTX) and methylprednisol... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34359372 | 19,716,433 | 2021-07-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Steroid diabetes'. | Efficacy and Tolerability of Methotrexate and Methylprednisolone in a Comparative Assessment of the Primary and Long-Term Outcomes in Patients with Pulmonary Sarcoidosis.
BACKGROUND
There is insufficient information in the literature on the comparative efficacy and tolerability of methotrexate (MTX) and methylprednisol... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34359372 | 19,707,425 | 2021-07-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
There is still limited data available from real-world experience studies on the pangenotypic regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis.... | RIBAVIRIN, SOFOSBUVIR, VELPATASVIR | DrugsGivenReaction | CC BY | 34362064 | 19,699,034 | 2021-07-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ascites'. | Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
There is still limited data available from real-world experience studies on the pangenotypic regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis.... | RIBAVIRIN, SOFOSBUVIR, VELPATASVIR | DrugsGivenReaction | CC BY | 34362064 | 19,699,034 | 2021-07-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
There is still limited data available from real-world experience studies on the pangenotypic regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis.... | RIBAVIRIN, SOFOSBUVIR, VELPATASVIR | DrugsGivenReaction | CC BY | 34362064 | 19,699,034 | 2021-07-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
There is still limited data available from real-world experience studies on the pangenotypic regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis.... | RIBAVIRIN, SOFOSBUVIR, VELPATASVIR | DrugsGivenReaction | CC BY | 34362064 | 19,699,034 | 2021-07-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
There is still limited data available from real-world experience studies on the pangenotypic regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis.... | RIBAVIRIN, SOFOSBUVIR, VELPATASVIR | DrugsGivenReaction | CC BY | 34362064 | 19,699,034 | 2021-07-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
There is still limited data available from real-world experience studies on the pangenotypic regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis.... | RIBAVIRIN, SOFOSBUVIR, VELPATASVIR | DrugsGivenReaction | CC BY | 34362064 | 19,699,034 | 2021-07-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic encephalopathy'. | Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
There is still limited data available from real-world experience studies on the pangenotypic regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis.... | RIBAVIRIN, SOFOSBUVIR, VELPATASVIR | DrugsGivenReaction | CC BY | 34362064 | 19,699,034 | 2021-07-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pruritus'. | Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
There is still limited data available from real-world experience studies on the pangenotypic regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis.... | RIBAVIRIN, SOFOSBUVIR, VELPATASVIR | DrugsGivenReaction | CC BY | 34362064 | 19,699,034 | 2021-07-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin disorder'. | Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics.
There is still limited data available from real-world experience studies on the pangenotypic regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis.... | RIBAVIRIN, SOFOSBUVIR, VELPATASVIR | DrugsGivenReaction | CC BY | 34362064 | 19,699,034 | 2021-07-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution.
Caplacizumab prevents platelet adhesion and has been approved for acquired thrombotic thrombocytopenic purpura (aTTP). This study was retrospective, including all patients diagnosed with aTTP and treated... | CAPLACIZUMAB, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34362201 | 19,717,934 | 2021-07-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution.
Caplacizumab prevents platelet adhesion and has been approved for acquired thrombotic thrombocytopenic purpura (aTTP). This study was retrospective, including all patients diagnosed with aTTP and treated... | CAPLACIZUMAB, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34362201 | 19,717,934 | 2021-07-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution.
Caplacizumab prevents platelet adhesion and has been approved for acquired thrombotic thrombocytopenic purpura (aTTP). This study was retrospective, including all patients diagnosed with aTTP and treated... | CAPLACIZUMAB, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34362201 | 19,717,934 | 2021-07-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution.
Caplacizumab prevents platelet adhesion and has been approved for acquired thrombotic thrombocytopenic purpura (aTTP). This study was retrospective, including all patients diagnosed with aTTP and treated... | CAPLACIZUMAB, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 34362201 | 19,717,934 | 2021-07-31 |
What was the dosage of drug 'PREDNISONE'? | Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution.
Caplacizumab prevents platelet adhesion and has been approved for acquired thrombotic thrombocytopenic purpura (aTTP). This study was retrospective, including all patients diagnosed with aTTP and treated... | 1 MG/KG OR HIGHER | DrugDosageText | CC BY | 34362201 | 19,717,934 | 2021-07-31 |
What was the dosage of drug 'VINCRISTINE'? | Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution.
Caplacizumab prevents platelet adhesion and has been approved for acquired thrombotic thrombocytopenic purpura (aTTP). This study was retrospective, including all patients diagnosed with aTTP and treated... | 2 MG WEEKLY | DrugDosageText | CC BY | 34362201 | 19,717,934 | 2021-07-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature.
Congenital anemias may be complicated by immune-mediated hemolytic crisis. Alloantibodies are usually seen in chronically transfused patients, and autoantibodies have also been described, although they are r... | AZATHIOPRINE, CYCLOPHOSPHAMIDE, PREDNISONE | DrugsGivenReaction | CC BY | 34362222 | 19,983,291 | 2021-08-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | ACETAMINOPHEN\HYDROCODONE, CERTOLIZUMAB PEGOL, MEROPENEM, METHYLPREDNISOLONE, PREDNISONE | DrugsGivenReaction | CC BY | 34362307 | 19,790,781 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperferritinaemia'. | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | ACETAMINOPHEN, ACETYLCYSTEINE, CERTOLIZUMAB PEGOL, GLUTATHIONE, MEROPENEM, METHYLPREDNISOLONE, PREDNISONE, URSODIOL | DrugsGivenReaction | CC BY | 34362307 | 19,811,630 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional overdose'. | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | ACETAMINOPHEN, ACETYLCYSTEINE, CERTOLIZUMAB PEGOL, GLUTATHIONE, PREDNISONE, URSODIOL | DrugsGivenReaction | CC BY | 34362307 | 19,835,486 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Low birth weight baby'. | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | ACETAMINOPHEN, ACETYLCYSTEINE, CERTOLIZUMAB PEGOL, GLUTATHIONE, MEROPENEM, METHYLPREDNISOLONE, PREDNISONE, URSODIOL | DrugsGivenReaction | CC BY | 34362307 | 19,811,597 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature baby'. | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | ACETAMINOPHEN, ACETYLCYSTEINE, CERTOLIZUMAB PEGOL, GLUTATHIONE, MEROPENEM, METHYLPREDNISOLONE, PREDNISONE, URSODIOL | DrugsGivenReaction | CC BY | 34362307 | 19,811,597 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | ACETAMINOPHEN, ACETYLCYSTEINE, CERTOLIZUMAB PEGOL, GLUTATHIONE, MEROPENEM, METHYLPREDNISOLONE, PREDNISONE, URSODIOL | DrugsGivenReaction | CC BY | 34362307 | 19,811,630 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Still^s disease'. | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | ACETAMINOPHEN, ACETYLCYSTEINE, CERTOLIZUMAB PEGOL, GLUTATHIONE, MEROPENEM, METHYLPREDNISOLONE, PREDNISONE, URSODIOL | DrugsGivenReaction | CC BY | 34362307 | 19,811,630 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transaminases increased'. | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | ACETAMINOPHEN | DrugsGivenReaction | CC BY | 34362307 | 19,817,902 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'White blood cell count increased'. | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | ACETAMINOPHEN, ACETYLCYSTEINE, CERTOLIZUMAB PEGOL, GLUTATHIONE, MEROPENEM, METHYLPREDNISOLONE, PREDNISONE, URSODIOL | DrugsGivenReaction | CC BY | 34362307 | 19,811,630 | 2021-08-06 |
What was the administration route of drug 'ACETAMINOPHEN'? | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | Oral | DrugAdministrationRoute | CC BY | 34362307 | 19,817,902 | 2021-08-06 |
What was the administration route of drug 'CERTOLIZUMAB PEGOL'? | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | Subcutaneous | DrugAdministrationRoute | CC BY | 34362307 | 19,835,486 | 2021-08-06 |
What was the dosage of drug 'MEROPENEM'? | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | UNKNOWN | DrugDosageText | CC BY | 34362307 | 19,790,781 | 2021-08-06 |
What was the outcome of reaction 'Drug-induced liver injury'? | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | Recovering | ReactionOutcome | CC BY | 34362307 | 19,835,486 | 2021-08-06 |
What was the outcome of reaction 'Intentional overdose'? | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | Recovering | ReactionOutcome | CC BY | 34362307 | 19,835,486 | 2021-08-06 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | Recovered | ReactionOutcome | CC BY | 34362307 | 19,835,486 | 2021-08-06 |
What was the outcome of reaction 'Overdose'? | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | Recovered | ReactionOutcome | CC BY | 34362307 | 19,817,902 | 2021-08-06 |
What was the outcome of reaction 'Transaminases increased'? | Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI.
BACKGROUND
Still's disease is a rare systemic inflammatory disease with frequent but generally mild liver involvement. The most common cause of acute liver failure in western countries is drug... | Recovering | ReactionOutcome | CC BY | 34362307 | 19,817,902 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urine sodium increased'. | A life-threatening case of pseudo-aldosteronism secondary to excessive liquorice ingestion.
BACKGROUND
Liquorice is found in many food products, soft drinks, and herbal medicines. Liquorice ingestion is an uncommon cause of apparent mineralocorticoid excess or pseudo-aldosteronism. The mechanism involves the inhibition... | AMILORIDE HYDROCHLORIDE\FUROSEMIDE, FUROSEMIDE, ISOSORBIDE DINITRATE, LERCANIDIPINE, POTASSIUM, SPIRONOLACTONE | DrugsGivenReaction | CC BY | 34362360 | 19,730,238 | 2021-08-06 |
What was the administration route of drug 'FUROSEMIDE'? | A life-threatening case of pseudo-aldosteronism secondary to excessive liquorice ingestion.
BACKGROUND
Liquorice is found in many food products, soft drinks, and herbal medicines. Liquorice ingestion is an uncommon cause of apparent mineralocorticoid excess or pseudo-aldosteronism. The mechanism involves the inhibition... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34362360 | 19,730,238 | 2021-08-06 |
What was the administration route of drug 'ISOSORBIDE DINITRATE'? | A life-threatening case of pseudo-aldosteronism secondary to excessive liquorice ingestion.
BACKGROUND
Liquorice is found in many food products, soft drinks, and herbal medicines. Liquorice ingestion is an uncommon cause of apparent mineralocorticoid excess or pseudo-aldosteronism. The mechanism involves the inhibition... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34362360 | 19,730,238 | 2021-08-06 |
What was the administration route of drug 'LERCANIDIPINE'? | A life-threatening case of pseudo-aldosteronism secondary to excessive liquorice ingestion.
BACKGROUND
Liquorice is found in many food products, soft drinks, and herbal medicines. Liquorice ingestion is an uncommon cause of apparent mineralocorticoid excess or pseudo-aldosteronism. The mechanism involves the inhibition... | Oral | DrugAdministrationRoute | CC BY | 34362360 | 19,730,238 | 2021-08-06 |
What was the administration route of drug 'POTASSIUM'? | A life-threatening case of pseudo-aldosteronism secondary to excessive liquorice ingestion.
BACKGROUND
Liquorice is found in many food products, soft drinks, and herbal medicines. Liquorice ingestion is an uncommon cause of apparent mineralocorticoid excess or pseudo-aldosteronism. The mechanism involves the inhibition... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34362360 | 19,730,238 | 2021-08-06 |
What was the administration route of drug 'SPIRONOLACTONE'? | A life-threatening case of pseudo-aldosteronism secondary to excessive liquorice ingestion.
BACKGROUND
Liquorice is found in many food products, soft drinks, and herbal medicines. Liquorice ingestion is an uncommon cause of apparent mineralocorticoid excess or pseudo-aldosteronism. The mechanism involves the inhibition... | Oral | DrugAdministrationRoute | CC BY | 34362360 | 19,730,238 | 2021-08-06 |
What was the dosage of drug 'AMILORIDE HYDROCHLORIDE\FUROSEMIDE'? | A life-threatening case of pseudo-aldosteronism secondary to excessive liquorice ingestion.
BACKGROUND
Liquorice is found in many food products, soft drinks, and herbal medicines. Liquorice ingestion is an uncommon cause of apparent mineralocorticoid excess or pseudo-aldosteronism. The mechanism involves the inhibition... | 40/5 MG, 20 MG/5 | DrugDosageText | CC BY | 34362360 | 19,730,238 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral infarction'. | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | MYCOPHENOLATE MOFETIL, SIROLIMUS | DrugsGivenReaction | CC BY | 34362398 | 20,481,367 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'IIIrd nerve paralysis'. | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | MYCOPHENOLATE MOFETIL, SIROLIMUS | DrugsGivenReaction | CC BY | 34362398 | 20,481,367 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Loss of proprioception'. | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34362398 | 20,493,028 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | ACYCLOVIR | DrugsGivenReaction | CC BY | 34362398 | 20,893,372 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sensory loss'. | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | GANCICLOVIR, TACROLIMUS, VALGANCICLOVIR | DrugsGivenReaction | CC BY | 34362398 | 20,484,324 | 2021-08-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Viral myelitis'. | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY | 34362398 | 20,493,028 | 2021-08-06 |
What was the administration route of drug 'ACYCLOVIR'? | The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation.
Epstein-Barr virus (EBV)-related neurologic complications have a diverse presentation in transplant recipients, creating diagnostic and therapeutic challenges for clinicians. In this case series, we report unique ma... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34362398 | 19,721,140 | 2021-08-06 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.